Literature DB >> 30185535

Cervical Cancer Burden and Opportunities for Prevention in a Safety-Net Healthcare System.

Sandi L Pruitt1,2, Claudia L Werner3,4, Eric K Borton5, Joanne M Sanders5, Bijal A Balasubramanian2,6, Arti Barnes7, Andrea C Betts5,8, Celette Sugg Skinner5,2, Jasmin A Tiro5,2.   

Abstract

BACKGROUND: The high prevalence of cervical cancer at safety-net health systems requires careful analysis to best inform prevention and quality improvement efforts. We characterized cervical cancer burden and identified opportunities for prevention in a U.S. safety-net system.
METHODS: We reviewed tumor registry and electronic health record (EHR) data of women with invasive cervical cancer with ages 18+, diagnosed between 2010 and 2015, in a large, integrated urban safety-net. We developed an algorithm to: (i) classify whether women had been engaged in care (≥1 clinical encounter between 6 months and 5 years before cancer diagnosis); and (ii) identify missed opportunities (no screening, no follow-up, failure of a test to detect cancer, and treatment failure) and associated factors among engaged patients.
RESULTS: Of 419 women with cervical cancer, more than half (58%) were stage 2B or higher at diagnosis and 40% were uninsured. Most (69%) had no prior healthcare system contact; 47% were diagnosed elsewhere. Among 122 engaged in care prior to diagnosis, failure to screen was most common (63%), followed by lack of follow-up (21%), and failure of test to detect cancer (16%). Tumor stage, patient characteristics, and healthcare utilization differed across groups.
CONCLUSIONS: Safety-net healthcare systems face a high cervical cancer burden, mainly from women with no prior contact with the system. To prevent or detect cancer early, community-based efforts should encourage uninsured women to use safety-nets for primary care and preventive services. IMPACT: Among engaged patients, strategies to increase screening and follow-up of abnormal screening tests could prevent over 80% of cervical cancer cases. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2018        PMID: 30185535      PMCID: PMC6314678          DOI: 10.1158/1055-9965.EPI-17-0912

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  35 in total

1.  Safety net integration: a shared strategy for becoming providers of choice.

Authors:  Julia Murphy; Michelle Ko; Kenneth W Kizer; Andrew B Bindman
Journal:  J Health Polit Policy Law       Date:  2015-02-02       Impact factor: 2.265

2.  Primary care and receipt of preventive services.

Authors:  A B Bindman; K Grumbach; D Osmond; K Vranizan; A L Stewart
Journal:  J Gen Intern Med       Date:  1996-05       Impact factor: 5.128

Review 3.  The role of Pap test screening against cervical cancer: a systematic review and meta-analysis.

Authors:  A Meggiolaro; B Unim; L Semyonov; S Miccoli; E Maffongelli; G La Torre
Journal:  Clin Ter       Date:  2016 Jul-Aug

4.  Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program.

Authors:  Jan F Nygård; Mari Nygård; Gry B Skare; Steinar Ø Thoresen
Journal:  Cancer Causes Control       Date:  2005-05       Impact factor: 2.506

5.  Diagnostic and therapeutic delays among a multiethnic sample of breast and cervical cancer survivors.

Authors:  Kimlin T Ashing-Giwa; Patricia Gonzalez; Jung-Won Lim; Cathie Chung; Benjamin Paz; George Somlo; Mark T Wakabayashi
Journal:  Cancer       Date:  2010-07-01       Impact factor: 6.860

6.  Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.

Authors:  Hazel Lewis; Li-Chia Yeh; Bobby Almendral; Harold Neal
Journal:  N Z Med J       Date:  2009-10-30

7.  Screening History in 313 Cases of Invasive Cancer: A Retrospective Review of Cervical Cancer Screening in Alberta, Canada.

Authors:  Silvina C Mema; Jill Nation; Huiming Yang; Ranjit Waghray; Maggie C Sun; Linan Xu; Gordon Kliewer
Journal:  J Low Genit Tract Dis       Date:  2017-01       Impact factor: 1.925

8.  Impact of Widespread Cervical Cancer Screening: Number of Cancers Prevented and Changes in Race-specific Incidence.

Authors:  Daniel X Yang; Pamela R Soulos; Brigette Davis; Cary P Gross; James B Yu
Journal:  Am J Clin Oncol       Date:  2018-03       Impact factor: 2.339

9.  Safety-net providers in some US communities have increasingly embraced coordinated care models.

Authors:  Peter Cunningham; Laurie Felland; Lucy Stark
Journal:  Health Aff (Millwood)       Date:  2012-08       Impact factor: 6.301

10.  Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?

Authors:  Alejandra Castanon; Rebecca Landy; Peter D Sasieni
Journal:  Int J Cancer       Date:  2016-05-06       Impact factor: 7.396

View more
  9 in total

1.  Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil.

Authors:  Philip E Castle; Vânia R S Silva; Marcia E L Consolaro; Nádia Kienen; Lorna Bittencourt; Sandra M Pelloso; Edward E Partridge; Amanda Pierz; Camila B Dartibale; Nelson S Uchimura; Isabel C Scarinci
Journal:  Cancer Prev Res (Phila)       Date:  2019-01-16

2.  Importance of primary care for underserved cancer patients with multiple chronic conditions.

Authors:  Katelyn K Jetelina; Simon Craddock Lee; Quiera S Booker-Nubie; Udoka C Obinwa; Hong Zhu; Michael E Miller; Navid Sadeghi; Umber Dickerson; Bijal A Balasubramanian
Journal:  J Cancer Surviv       Date:  2022-01-05       Impact factor: 4.062

3.  Racial and Ethnic Differences in Acceptability of Urine and Cervico-Vaginal Sample Self-Collection for HPV-Based Cervical Cancer Screening.

Authors:  Eliane Rohner; F Hunter McGuire; Yutong Liu; Quefeng Li; Kate Miele; Samveg A Desai; John W Schmitt; Andrea Knittel; Julie A E Nelson; Claire Edelman; Vijay Sivaraman; Anna Baker; LaHoma S Romocki; Lisa Rahangdale; Jennifer S Smith
Journal:  J Womens Health (Larchmt)       Date:  2020-03-26       Impact factor: 2.681

4.  Test Accuracy of Human Papillomavirus in Urine for Detection of Cervical Intraepithelial Neoplasia.

Authors:  Eliane Rohner; Lisa Rahangdale; Busola Sanusi; Andrea K Knittel; Laurence Vaughan; Kirsty Chesko; Brian Faherty; Samantha E Tulenko; John W Schmitt; LaHoma S Romocki; Vijay Sivaraman; Julie A E Nelson; Jennifer S Smith
Journal:  J Clin Microbiol       Date:  2020-02-24       Impact factor: 5.948

5.  Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening.

Authors:  Eliane Rohner; Claire Edelman; Busola Sanusi; John W Schmitt; Anna Baker; Kirsty Chesko; Brian Faherty; Sean M Gregory; LaHoma S Romocki; Vijay Sivaraman; Julie A E Nelson; Siobhan O'Connor; Michael G Hudgens; Andrea K Knittel; Lisa Rahangdale; Jennifer S Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09-17       Impact factor: 4.254

6.  A population study of screening history and diagnostic outcomes of women with invasive cervical cancer.

Authors:  Vicki B Benard; J Elizabeth Jackson; April Greek; Virginia Senkomago; Warner K Huh; Cheryll C Thomas; Lisa C Richardson
Journal:  Cancer Med       Date:  2021-05-21       Impact factor: 4.452

7.  Thematic Analysis of Challenges of Care Coordination for Underinsured and Uninsured Cancer Survivors With Chronic Conditions.

Authors:  Bijal A Balasubramanian; Robin T Higashi; Serena A Rodriguez; Navid Sadeghi; Noel O Santini; Simon Craddock Lee
Journal:  JAMA Netw Open       Date:  2021-08-02

8.  Letter to the Editor Re: A population study of screening history and diagnostic outcomes of women with invasive cervical cancer.

Authors:  Philip E Castle
Journal:  Cancer Med       Date:  2021-08-26       Impact factor: 4.452

9.  Symptomatic presentation of cervical cancer in emergency departments in California.

Authors:  Frances B Maguire; Julianne J P Cooley; Cyllene R Morris; Arti Parikh-Patel; Vanessa A Kennedy; Theresa H M Keegan
Journal:  Cancer Causes Control       Date:  2021-08-23       Impact factor: 2.506

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.